Cargando…
A new approach for cellular immunotherapy of nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated malignancy that is highly prevalent in Southern China and South-East Asia. EBV-targeted immunotherapy remains a goal in the development of novel treatment strategies. A novel adenoviral polyepitope-based immunotherapy has been...
Autores principales: | Smith, Corey, Khanna, Rajiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518531/ https://www.ncbi.nlm.nih.gov/pubmed/23243622 http://dx.doi.org/10.4161/onci.21286 |
Ejemplares similares
-
Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment
por: Schuessler, Andrea, et al.
Publicado: (2014) -
New insights into the role of NK cells in cancer immunotherapy
por: Salagianni, Maria, et al.
Publicado: (2012) -
Adoptive immunotherapy: New assay for the identification of T cells with optimal avidity
por: Weissbrich, Bianca, et al.
Publicado: (2013) -
Overcoming resistance to immunotherapy by teaching old drugs new tricks
por: Perry, John M., et al.
Publicado: (2020) -
“Suffocating” tumors by blocking adaptation to hypoxia: a new headway in melanoma immunotherapy
por: Janji, Bassam, et al.
Publicado: (2021)